Harmony Biosciences Holdings (HRMY) Cash from Operations Growth (1y) (2020 - 2026)
Harmony Biosciences Holdings (HRMY) Cash from Operations Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 60.84% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 85.14% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.72% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 74.39% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Harmony Biosciences Holdings | 1.92 Bn | 1.28 Bn | 170.88 Mn | -18.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.32% |
| Dec 31, 2025 | 66.95% |
| Sep 30, 2025 | 54.23% |
| Jun 30, 2025 | 86.14% |
| Mar 31, 2025 | 9.14% |
| Dec 31, 2024 | -1.44% |
| Sep 30, 2024 | 11.73% |
| Jun 30, 2024 | 14.99% |
| Mar 31, 2024 | -26.83% |
| Dec 31, 2023 | 187.37% |
| Sep 30, 2023 | 14.30% |
| Jun 30, 2023 | 9.88% |
| Mar 31, 2023 | 47.51% |
| Dec 31, 2022 | -28.92% |
| Sep 30, 2022 | 81.45% |
| Jun 30, 2022 | 86.67% |
| Mar 31, 2022 | 130.26% |
| Dec 31, 2021 | 273.57% |
| Sep 30, 2021 | 244.24% |
| Jun 30, 2021 | 273.97% |